Insider · CIK 0001813798
Jim Wassil
cooofficer
Files at PCVX (Vaxcyte, Inc.). First filing Nov 3, 2023, latest Oct 7, 2026.
In brief
Jim Wassil files SEC Form 4 as COO at PCVX (Vaxcyte, Inc.). Since Nov 3, 2023, Jim Wassil has reported 0 open-market buys worth $0 and 14 open-market sells worth $5.0M, the latest filed on Oct 7, 2026.
A track record needs three past buys with six months of prices behind them; Jim Wassil has 0, so none is measured yet.
The newest scored trade: sold $1.6M of PCVX on Oct 5, 2026, filed Oct 7, 2026, scored 23 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 10 sells worth $3.1M.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 14
$0 bought, $5.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PCVX: Vaxcyte, Inc.
PCVXOct 9, 2026 · close 71.38
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Vaxcyte, Inc. | $1.6M 18,000 shares | -11% | +83% from low0% from high | |
| 4Weak | Vaxcyte, Inc. | $128k 2,250 shares | -2% | +47% from low-11% from high | |
| 11Weak | Vaxcyte, Inc. | $164k 2,715 shares | -2% | +98% from low-3% from high | |
| 0Weak | Vaxcyte, Inc. | $212k 3,477 shares | -2% | +97% from low-4% from high | |
| 10Weak | Vaxcyte, Inc. | $121k 2,250 shares | -1% | +80% from low-15% from high | |
| 11Weak | Vaxcyte, Inc. | $127k 2,250 shares | -1% | +89% from low-11% from high | |
| 10Weak | Vaxcyte, Inc. | $111k 2,250 shares | -1% | +65% from low-22% from high | |
| 11Weak | Vaxcyte, Inc. | $128k 2,250 shares | -1% | +96% from low-10% from high | |
| 19Weak | Vaxcyte, Inc. | $131k 2,250 shares | -1% | +109% from low-7% from high | |
| 25Weak | Vaxcyte, Inc. | $435k 7,395 shares | -4% | +108% from low-24% from high | |
| 21Weak | Vaxcyte, Inc. | $740k 8,000 shares | -4% | - | |
| 23Weak | Vaxcyte, Inc. | $854k 8,000 shares | -4% | - | |
| 11Weak | Vaxcyte, Inc. | $156k 3,000 shares | -2% | +55% from low-0% from high | |
| 11Weak | Vaxcyte, Inc. | $142k 3,000 shares | -2% | +38% from low-11% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | 18,000 0.01% of outstanding | $1.6M | Oct 5, 2026 | $625k |
| Oct 1, 2026 | PCVX Vaxcyte, Inc. | 2,250 0.00% of outstanding | $128k | Oct 1, 2026 | $624k |
| Sep 9, 2026 | PCVX Vaxcyte, Inc. | 1,334 0.00% of outstanding | $80k | Sep 9, 2026 | $545k |
| Sep 4, 2026 | PCVX Vaxcyte, Inc. | 1,381 0.00% of outstanding | $82k | Sep 4, 2026 | $460k |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | 3,477 0.00% of outstanding | $210k | Sep 1, 2026 | $359k |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | 2,250 0.00% of outstanding | $121k | Aug 3, 2026 | $238k |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | 2,250 0.00% of outstanding | $131k | Jul 1, 2026 | $371k |
| Jun 1, 2026 | PCVX Vaxcyte, Inc. | 2,250 0.00% of outstanding | $115k | Jun 1, 2026 | $695k |
| May 1, 2026 | PCVX Vaxcyte, Inc. | 2,250 0.00% of outstanding | $129k | May 1, 2026 | $567k |
| Apr 1, 2026 | PCVX Vaxcyte, Inc. | 2,250 0.00% of outstanding | $131k | Apr 1, 2026 | $435k |
| Mar 10, 2026 | PCVX Vaxcyte, Inc. | 7,395 0.01% of outstanding | $432k | Mar 10, 2026 | none |
| Mar 3, 2025 | PCVX Vaxcyte, Inc. | 8,000 0.01% of outstanding | $585k | Mar 3, 2025 | $1.4M |
| Feb 3, 2025 | PCVX Vaxcyte, Inc. | 8,000 0.01% of outstanding | $706k | Feb 3, 2025 | $1.4M |
| Jan 2, 2025 | PCVX Vaxcyte, Inc. | 8,000 0.01% of outstanding | $661k | Jan 2, 2025 | $1.6M |
| Dec 2, 2024 | PCVX Vaxcyte, Inc. | 8,000 0.01% of outstanding | $752k | Dec 2, 2024 | $4.0M |
| Nov 1, 2024 | PCVX Vaxcyte, Inc. | 8,000 0.01% of outstanding | $854k | Nov 1, 2024 | $3.4M |
| Mar 1, 2024 | PCVX Vaxcyte, Inc. | 3,000 0.00% of outstanding | $224k | Mar 1, 2024 | $570k |
| Feb 1, 2024 | PCVX Vaxcyte, Inc. | 3,000 0.00% of outstanding | $215k | Feb 1, 2024 | $490k |
| Jan 2, 2024 | PCVX Vaxcyte, Inc. | 3,000 0.00% of outstanding | $186k | Jan 2, 2024 | $449k |
| Dec 1, 2023 | PCVX Vaxcyte, Inc. | 3,000 0.00% of outstanding | $155k | Dec 1, 2023 | $452k |
| Nov 1, 2023 | PCVX Vaxcyte, Inc. | 3,000 0.00% of outstanding | $144k | Nov 1, 2023 | $310k |
Transactions
The newest 50 of 72 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +18,000 | $5.35 | $96k | 163,435 | 6 d ago |
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -18,000 | $86.74 | $1.6M | 145,435 | 6 d ago |
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -18,000 | $0.00 | $0 | 46,398 | 6 d ago |
| Oct 1, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +2,250 | $5.35 | $12k | 147,685 | 11 d ago |
| Oct 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -2,155 | $56.65 | $122k | 145,530 | 11 d ago |
| Oct 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -95 | $57.09 | $5,424 | 145,435 | 11 d ago |
| Oct 1, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,250 | $0.00 | $0 | 64,398 | 11 d ago |
| Sep 4, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,381 | $61.16 | $84k | 152,228 | 34 d ago |
| Sep 8, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -5,459 | $60.36 | $330k | 146,769 | 34 d ago |
| Sep 9, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,334 | $59.52 | $79k | 145,435 | 34 d ago |
| Aug 31, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,273 | $60.74 | $77k | 156,268 | 41 d ago |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock | +2,250 | $5.35 | $12k | 158,518 | 41 d ago |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,537 | $60.89 | $94k | 156,981 | 41 d ago |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -713 | $61.48 | $44k | 156,268 | 41 d ago |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -924 | $60.96 | $56k | 155,344 | 41 d ago |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -303 | $61.42 | $19k | 155,041 | 41 d ago |
| Sep 2, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,432 | $61.58 | $88k | 153,609 | 41 d ago |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative | -2,250 | $0.00 | $0 | 66,648 | 41 d ago |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +2,250 | $5.35 | $12k | 159,791 | Aug 5, 2026 |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -861 | $53.50 | $46k | 158,930 | Aug 5, 2026 |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,389 | $54.09 | $75k | 157,541 | Aug 5, 2026 |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,250 | $0.00 | $0 | 68,898 | Aug 5, 2026 |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +516 | $5.35 | $2,761 | 159,010 | Jul 6, 2026 |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,788 | $56.03 | $100k | 157,222 | Jul 6, 2026 |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -456 | $57.47 | $26k | 156,766 | Jul 6, 2026 |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -6 | $57.82 | $347 | 156,760 | Jul 6, 2026 |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -516 | $0.00 | $0 | 71,148 | Jul 6, 2026 |
| Jun 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,949 | $49.40 | $96k | 158,795 | Jun 3, 2026 |
| Jun 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -301 | $50.26 | $15k | 158,494 | Jun 3, 2026 |
| May 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -2,250 | $56.83 | $128k | 160,744 | May 1, 2026 |
| Apr 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,412 | $58.14 | $82k | 165,406 | Apr 3, 2026 |
| Apr 1, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -838 | $58.93 | $49k | 162,994 | Apr 3, 2026 |
| Mar 9, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock10b5-1 | -975 | $59.32 | $58k | 174,213 | Mar 11, 2026 |
| Mar 10, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -2,427 | $58.32 | $142k | 171,786 | Mar 11, 2026 |
| Mar 10, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -4,968 | $59.16 | $294k | 166,818 | Mar 11, 2026 |
| Feb 26, 2026 | PCVX Vaxcyte, Inc. | AGrant or award Common Stock | +32,045 | $0.00 | $0 | 173,893 | Mar 2, 2026 |
| Feb 27, 2026 | PCVX Vaxcyte, Inc. | AGrant or award Common Stock | +5,102 | $61.74 | $315k | 178,995 | Mar 2, 2026 |
| Feb 27, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,900 | $61.74 | $117k | 177,095 | Mar 2, 2026 |
| Feb 28, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -898 | $61.98 | $56k | 176,197 | Mar 2, 2026 |
| Mar 2, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,009 | $61.98 | $63k | 175,188 | Mar 2, 2026 |
| Feb 26, 2026 | PCVX Vaxcyte, Inc. | AGrant or award Stock Option (right to buy)derivative | +53,566 | $0.00 | $0 | 53,566 | Mar 2, 2026 |
| Sep 8, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -2,759 | $32.41 | $89k | 141,848 | Sep 10, 2025 |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,270 | $31.56 | $40k | 149,286 | Sep 4, 2025 |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,587 | $31.56 | $50k | 147,699 | Sep 4, 2025 |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,429 | $31.56 | $45k | 146,270 | Sep 4, 2025 |
| Dec 2, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $2.42 | $19k | 213,695 | Dec 3, 2024 |
| Dec 2, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -5,772 | $92.07 | $531k | 207,923 | Dec 3, 2024 |
| Dec 2, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,101 | $93.06 | $102k | 206,822 | Dec 3, 2024 |
| Dec 2, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,127 | $94.06 | $106k | 205,695 | Dec 3, 2024 |
| Dec 2, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 18,638 | Dec 3, 2024 |
50 of 72 rows shown.
Questions about Jim Wassil
Answered from the filings on this page, as of the latest one.
Is Jim Wassil buying or selling?
In the last 12 months Jim Wassil reported 0 open-market buys worth $0 and 10 open-market sells worth $3.1M on SEC Form 4; the latest was sold $1.6M of PCVX on Oct 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Jim Wassil's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jim Wassil has 0.
Where does Jim Wassil file Form 4?
Jim Wassil has filed Form 4 at PCVX (Vaxcyte, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.